1. Real-world evaluation of effectiveness and tolerance of chemotherapy for early-stage breast cancer in older women

   • Glenda M. Delgado-Ramos
   • Syed Sameer Nasir
   • Lee S. Schwartzberg

   Review 23 May 2020 Pages: 247 - 258

   

2. Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancer

   • Daniel Reinhorn
   • Rinat Yerushalmi
   • Hadar Goldvaser

   Review 01 June 2020 Pages: 259 - 266

   

3. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival

   • Chitra Joseph
   • Mansour Alsaleem
   • Emad A. Rakha

   Preclinical study Open access 22 May 2020 Pages: 267 - 282

   

4. Diffusion-weighted MRI at 3.0 T for detection of occult disease in the contralateral breast in women with newly diagnosed breast cancer

   • Su Min Ha
   • Jung Min Chang
   • Woo Kyung Moon

   Clinical trial 23 May 2020 Pages: 283 - 297

   

5. A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers

   • Minna K. Lee
   • Yas Sanaiha
   • Maggie L. DiNome

   Clinical trial 25 May 2020 Pages: 299 - 303

   

6. Sensory profiles in women with neuropathic pain after breast cancer surgery

   • L. Mustonen
   • J. Vollert
   • H. Harno

   Clinical trial Open access 27 May 2020 Pages: 305 - 315

   

7. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes

   • Zeina Hassan
   • Fouad Boulos
   • Eman Sbaity

   Clinical trial 28 May 2020 Pages: 317 - 323

8. NSAS-BC02 substudy of chemotherapy-induced amenorrhea (CIA) in premenopausal patients who received either taxane alone or doxorubicin(A) cyclophosphamide(C) followed by taxane as postoperative chemotherapy

   • Takayuki Iwamoto
   • Fumikata Hara
   • Yasuo Ohashi

   Clinical Trial 28 May 2020 Pages: 325 - 332

   

9. Cumulative incidence of chemotherapy-induced cardiotoxicity during a 2-year follow-up period in breast cancer patients

   • Hyunsoon Cho
   • Sanghee Lee
   • Hak Jin Kim

   Clinical trial 28 May 2020 Pages: 333 - 343

   

10. Predictive risk factors of complications in different breast reconstruction methods

    • J. S. Palve
    • T. H. Luukkaala
    • M. T. Kääriäinen

    Clinical trial Open access 28 May 2020 Pages: 345 - 354

11. Cost-effectiveness analysis of endocrine therapy alone versus partial-breast irradiation alone versus combined treatment for low-risk hormone-positive early-stage breast cancer in women aged 70 years or older

    • Matthew C. Ward
    • Frank Vicini
    • Chirag Shah

    Clinical trial 28 May 2020 Pages: 355 - 365

    

12. Utilization patterns and temporal trends of internal mammary nodal irradiation at a tertiary cancer center

    • Shagun Misra
    • Grace Lee
    • C. Anne Koch

    Clinical trial 30 May 2020 Pages: 367 - 379

    

13. Risk factors for skeletal-related events in patients with bone metastasis from breast cancer undergoing treatment with zoledronate

    • Hirotaka Miyashita
    • Christina Cruz
    • Stephen Malamud

    Clinical trial 30 May 2020 Pages: 381 - 388

    

14. Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study

    • S. Krajnak
    • C. Schnatz
    • M. J. Battista

    Clinical trial Open access 03 June 2020 Pages: 389 - 399

    

15. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study

    • Giuseppe Buono
    • Anna Crispo
    • Grazia Arpino

    Clinical trial Open access 04 June 2020 Pages: 401 - 409

    

16. Radiation and/or endocrine therapy? Recurrence and survival outcomes in women over 70 with early breast cancer after breast-conserving surgery

    • Hannah Dahn
    • Derek Wilke
    • Jean-Philippe Pignol

    Epidemiology 21 May 2020 Pages: 411 - 420

    

17. Cancer risk management among female BRCA1/2, PALB2, CHEK2, and ATM carriers

    • Deborah Cragun
    • Anne Weidner
    • Tuya Pal

    Epidemiology 22 May 2020 Pages: 421 - 428

    

18. Does oncoplastic surgery increase immediate (30-day) postoperative complications? An analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database

    • Fernando A. Angarita
    • Sergio A. Acuna
    • Tulin D. Cil

    Epidemiology 25 May 2020 Pages: 429 - 438

    

19. Overall health at diagnosis predicts the risk of complications within the first year after breast cancer diagnosis

    • Cecilia T. Ong
    • Yi Ren
    • Rachel A. Greenup

    Epidemiology 28 May 2020 Pages: 439 - 449

    

20. Gut microbiome associations with breast cancer risk factors and tumor characteristics: a pilot study

    • Anna H. Wu
    • Chiuchen Tseng
    • Darcy Spicer

    Epidemiology Open access 28 May 2020 Pages: 451 - 463

    

21. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis

    • Blanche P. Alter
    • Ana F. Best

    Epidemiology 02 June 2020 Pages: 465 - 476

    

22. Stage-specific survival has improved for young breast cancer patients since 2000: but not equally

    • Cassia Bree Trewin
    • Anna Louise Viktoria Johansson
    • Giske Ursin

    Epidemiology Open access 03 June 2020 Pages: 477 - 489

    

23. Simple prediction model for homologous recombination deficiency in breast cancers in adolescents and young adults

    • Tomoko Watanabe
    • Takayuki Honda
    • Takashi Kohno

    Epidemiology 03 June 2020 Pages: 491 - 502

    

24. Somatic mutations of triple-negative breast cancer: a comparison between Black and White women

    • Angela R. Omilian
    • Lei Wei
    • Song Yao

    Brief report 21 May 2020 Pages: 503 - 509

    

25. Response to the article by Dietz et al. entitled “Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID‑19 pandemic. The COVID‑19 pandemic breast cancer consortium”

    • Peter Beitsch
    • Pat Whitworth
    • Rakesh Patel

    Letter to the Editor 26 May 2020 Pages: 511 - 512

26. Reply to letters to the editor: Discordance in estrogen receptor and change of Ki67 between primary site and metastatic site of recurrent breast cancer

    • Junichiro Watanabe

    Rebuttal Letter 21 May 2020 Pages: 513 - 514